Selected Publications

Vollenweider FX, Preller KH (2020): Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders. Nat Rev Neurosci 21:611-624.

Mertens LJ, Preller KH (2020): Classical Psychedelics as Therapeutics in Psychiatry – Current clinical evidence and potential therapeutic mechanisms in substance use and mood disorders. Pharmacopsychiatry in press.

Leptourgos P, Fortier-Davy M, Carhart-Harris R, Corlett PR, Dupuis D, Halberstadt AL, Kometer M, Kozakova E, Laroi F, Noorani TN, Preller KH, Waters F, Zaytseva Y, Jardri R (2020): Hallucinations under psychedelics and in the schizophrenia spectrum: An interdisciplinary and multiscale comparison. Schizophr Bull in press.

Duerler P, Schilbach L, Stämpfli P, Vollenweider FX, Preller KH (2020): LSD-induced increases in social adaptation to opinions similar to one's own are associated with stimulation of serotonin receptors. Sci Rep 10: 12181.

Preller KH, Duerler P, Burt JB, Ji JL, Adkinson B, Stämpfli P, Seifritz E, Repovs G, Krystal JH, Murray JD, Anticevic A, Vollenweider FX (2020): Psilocybin induces time-dependent changes in global functional connectivity. Biol Psychiatry 88:197-207.

Preller KH & Vollenweider FX (2019): Modulation of social cognition via hallucinogens and entactogens. Front Psychiatry 10:881.

Preller KH (2019): The effects of low doses of LSD in healthy humans: Demystifying the microdosing of psychedelics. Biol Psychiatry (in press).

Pokorny T, Duerler P, Seifritz E, Vollenweider FX, Preller KH (2019): LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision making. Psychol Med (in press).

Preller KH, Razi A, Zeidman P, Stämpfli P, Friston KJ, Vollenweider FX (2019): Effective connectivity changes in LSD-induced altered states of consciousness in humans. Proc Natl Acad Sci USA 116(7):2743-2748.

Friston KJ, Preller KH, Mathys C, Cagnan H, Heinzle J, Razi A, Zeidman P (2019): Dynamic causal modelling revisited. Neuroimage 199:730-744.

Preller KH, Burt JB, Ji JL, Schleifer C, Adkinson B, Stämpfli P, Repovs G, Krystal JH, Murray JD, Seifritz E, Vollenweider FX, Anticevic A (2018): Changes in resting-state global brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. eLife 25;7. pii: e35082.

Preller KH, Schilbach L, Pokorny T, Flemming J, Seifritz E, Vollenweider FX (2018): Role of the 5-HT2A Receptor in Self- and Other-Initiated Social Interaction in Lysergic Acid Diethylamide-Induced States: A Pharmacological fMRI Study. J Neurosci 38:3603-3611.

Barrett FS*, Preller KH*, Kaelen M* (2018): Psychedelics and music: Neuroscience and therapeutic implications. Int Rev Psychiatry 21:1-13. *equal contribution.

Rigoli F*, Preller KH*, Dolan RJ (2018): Risk preference and choice stochasticity during decisions for other people. Cogn Affect Behav Neurosc 18:331-341 *equal contribution.

Preller KH, Herdener M, Pokorny T, Planzer A, Kraehenmann R, Stämpfli P, Liechti M, Seifritz E, Vollenweider FX (2017): The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation. Current Biol 27:451-457.

Preller KH, Pokorny T, Hock A, Kraehenmann R, Stämpfli P, Seifritz E, Scheidegger M, Vollenweider FX (2016): Effects of serotonin 2A/1A receptor stimulation on social exclusion processing. Proc Natl Acad Sci USA 113:5119-24.

Complete publication list